Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
about
High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced DamageModeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesAn Integrin-Targeting RGDK-Tagged Nanocarrier: Anticancer Efficacy of Loaded Curcumin.Anthracycline or trastuzumab-related cardiotoxicity: do we have a predictive biomarker?Alternative Biomarkers for Combined Biology.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging.Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.Network and Pathway Analysis of Toxicogenomics Data
P2860
Q35681478-255E32BB-BB3C-49F6-85D7-6243A75D737BQ36864827-00C0CF13-5EDA-40AB-8759-58E1D251E7B1Q38288371-D1D4FD80-8DC6-430B-83C1-18CF22FCAA19Q38727423-4EEC306F-0F11-4F3A-B460-50407554DD68Q38747992-66EEB206-995C-4B75-8554-5B77BACD966EQ38874111-DB5B5A56-8AD3-4B70-853C-5D0DBB52FCD9Q40026732-B83514A7-B517-4F21-B0E4-383D7F42917EQ40775564-15571B32-F999-4AE3-BCD2-E0093C8FDD67Q47611653-7B30C3DD-ED75-4E00-A48D-AC489825EF84Q48353831-599CA771-6124-4C8C-AF80-56BAFF66A068Q50611647-A6AC803E-0443-42AD-94AF-8CB90BF59DBDQ55265082-55AD41FE-07D1-4D98-81BF-80AD6B0123FAQ58580378-D003F3AF-6153-45F1-97C2-ABA75005E3D5
P2860
Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Identification of novel biomar ...... d from pluripotent stem cells.
@ast
Identification of novel biomar ...... d from pluripotent stem cells.
@en
type
label
Identification of novel biomar ...... d from pluripotent stem cells.
@ast
Identification of novel biomar ...... d from pluripotent stem cells.
@en
prefLabel
Identification of novel biomar ...... d from pluripotent stem cells.
@ast
Identification of novel biomar ...... d from pluripotent stem cells.
@en
P2093
P2860
P1433
P1476
Identification of novel biomar ...... ed from pluripotent stem cells
@en
P2093
Caroline Améen
Gustav Holmgren
Karolina Åkesson
Peter Sartipy
Sandra Holmgren
Yalda Bogestål
P2860
P304
P356
10.1016/J.TOX.2014.12.018
P407
P577
2014-12-18T00:00:00Z